Publications

Filters

Publications Atlas Journal Article Research Report

Clinical and Practice Brain diseases Cancer and cancer screening Cardiovascular disease Chronic diseases and multimorbidity Diet and nutrition Endocrinology Environmental health Eye, ear, nose and throat disorders Gastroenterology Hematology Infectious diseases Injuries and accidents Internal medicine Kidney disease Lung health Musculoskeletal diseases and disorders Organ transplantation and donation Pharmacoepidemiology and drug safety Reproductive medicine Skin diseases and disorders

Healthcare Providers and Services Acute and emergency services End-of-life care Home and community care Long-term care and continuing care Maternity and neonatal care Mental health and addictions Nursing Pediatrics Pharmacy Primary care Public health Rehabilitation Surgery

People and Society Children and young people Health and healthcare inequality Indigenous Peoples Marginalized populations Older people Racialized communities Women or gender-based research

Research and Methods Data science Decision science Epidemiology Health economics Health services research Implementation science and knowledge translation Policy and program evaluation Statistics Trials

From

ICES Central ICES McMaster ICES North ICES Queen's ICES UofT ICES uOttawa ICES Western

Cancer Cardiovascular Chronic Disease & Pharmacotherapy Kidney, Dialysis & Transplantation Life Stage Mental Health & Addictions Populations & Public Health Primary Care & Health Systems

Showing 1-10 of 42

Journal Article

22/09/2022

Estimated effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes

Buchan SA, Chung H, Brown KA, Austin PC, Fell DB, Gubbay JB, Nasreen S, Schwartz KL, Sundaram ME, Tadrous M, Wilson K, Wilson SE, Kwong JC. JAMA Netw Open. 2022; 5(9):e2232760. Epub 2022 Sep 22.

Journal Article

07/09/2022

Effectiveness of COVID-19 vaccines over time prior to Omicron emergence in Ontario, Canada: test-negative design study

Chung H, Austin PC, Brown KA, Buchan SA, Fell DB, Fong C, Gubbay JB, Nasreen S, Schwartz KL, Sundaram ME, Tadrous M, Wilson K, Wilson SE, Kwong JC; on behalf of the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. Open Forum Infect Dis. 2022; Sep 7 [Epub ahead of print].

Journal Article

17/08/2022

Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: a multiprovincial test-negative design study

Nasreen S, Febriani Y, García HAV, Zhang G, Tadrous M, Buchan SA, Righolt CH, Mahmud SM, Janjua NZ, Krajden M, De Serres G, Kwong JC; Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. Clin Infect Dis. 2022; Aug 17 [Epub ahead of print].

Journal Article

06/07/2022

Effectiveness of a fourth dose of COVID-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study

Grewal R, Kitchen SA, Nguyen L, Buchan SA, Wilson SE, Costa AP, Kwong JC. BMJ. 2022; 378:e071502. Epub 2022 Jul 6.

Journal Article

16/06/2022

Vaccine effectiveness of BNT162b2 against Delta and Omicron variants in adolescents

Buchan SA, Nguyen L, Wilson SE, Kitchen SA, Kwong JC. Pediatrics. 2022; Jun 16 [Epub ahead of print].

Journal Article

27/04/2022

Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance

Nasreen S, Calzavara A, Buchan SA, Thampi N, Johnson C, Wilson SE, Kwong JC; on behalf of the Canadian Immunization Research Network CIRN Provincial Collaborative Network PCN Ontario investigators. Vaccine. 2022; 40(24):3305-12. Epub 2022 Apr 27.

Journal Article

29/03/2022

Screening large population health databases for potential coronavirus disease 2019 therapeutics: a pharmacopeia-wide association study of commonly prescribed medications

MacFadden DR, Brown K, Buchan SA, Chung H, Kozak R, Kwong JC, Manuel D, Mubareka S, Daneman N. Open Forum Infect Dis. 2022; 9(5):ofac156. Epub 2022 Mar 29.

Journal Article

07/02/2022

Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario

Nasreen S, Chung H, He S, Brown KA, Gubbay JB, Buchan SA, Fell DB, Austin PC, Schwartz KL, Sundaram ME, Calzavara A, Chen B, Tadrous M, Wilson K, Wilson SE, Kwong JC; Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. Nat Microbiol. 2022; 7(3):379-85. Epub 2022 Feb 7.

Journal Article

18/11/2021

A multi-country investigation of influenza vaccine coverage in pregnant individuals, 2010-2016

Irving SA, Ball SW, Booth SM, Regan AK, Naleway AL, Buchan SA, Katz MA, Effler PV, Svenson LW, Kwong JC, Feldman BS, Klein NP, Chung H, Simmonds K; PREVENT study team. Vaccine. 2021; 39(52):7598-605. Epub 2021 Nov 18.

Journal Article

20/08/2021

Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study

Chung H, He S, Nasreen S, Sundaram ME, Buchan SA, Wilson SE, Chen B, Calzavara A, Fell DB, Austin PC, Wilson K, Schwartz KL, Brown KA, Gubbay JB, Basta NE, Mahmud SM, Righolt CH, Svenson LW, MacDonald SE, Janjua NZ, Tadrous M, Kwong JC; on behalf of the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. BMJ. 2021; 374:n1943. Epub 2021 Aug 20.

« Previous 1 2 3 4 5 Next »

Publications

Filters

Resource Type

Topic

Date

ICES Scientists

ICES Site

Research Program

Estimated effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes

Effectiveness of COVID-19 vaccines over time prior to Omicron emergence in Ontario, Canada: test-negative design study

Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: a multiprovincial test-negative design study

Effectiveness of a fourth dose of COVID-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study

Vaccine effectiveness of BNT162b2 against Delta and Omicron variants in adolescents

Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance

Screening large population health databases for potential coronavirus disease 2019 therapeutics: a pharmacopeia-wide association study of commonly prescribed medications

Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario

A multi-country investigation of influenza vaccine coverage in pregnant individuals, 2010-2016

Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study